Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse.
Voruganti
L N
LN
Department of Psychiatry, University of Western Ontario, London Health Sciences Centre (Victoria Campus), Canada.
Heslegrave
R J
RJ
Awad
A G
AG
D000328:Adult; D000342:Affective Symptoms / Q000139:chemically induced* / Q000453:epidemiology / Q000517:prevention & control*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015897:Comorbidity; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008297:Male; D012559:Schizophrenia / Q000188:drug therapy* / Q000453:epidemiology; D012565:Schizophrenic Psychology; D012651:Self Medication; D019966:Substance-Related Disorders / Q000453:epidemiology / Q000209:etiology*
D014150:Antipsychotic Agents